Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Silvia N, Tenembaum"'
Autor:
Silvia N. Tenembaum
Publikováno v:
Clinical and Experimental Neuroimmunology. 12:7-21
Autor:
Silvia N. Tenembaum
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 5 (2012)
Children and adolescents with multiple sclerosis (MS) are reported to show high rates of relapse early in the course of the disease as well as cognitive deterioration over time. Immunomodulatory therapies developed for adult MS patients are currently
Externí odkaz:
https://doaj.org/article/a04dbd1c85f24345af83e2b3b50f55c4
Autor:
Silvia N. Tenembaum
Publikováno v:
Acta Neurológica Colombiana, Vol 22, Iss 2 (2006)
La encefalomielitis aguda diseminada, la esclerosis múltiple, la neuritis óptica, la mielitis transversa y la neuromielitis óptica son algunos ejemplos de trastornos desmielinizantes, cuyos criterios diagnósticos en adultos son objeto de revisió
Externí odkaz:
https://doaj.org/article/f8eeb18aa795425db8ba177745b29c26
Autor:
Silvia N. Tenembaum
Publikováno v:
Neuroimaging Clinics of North America. 27:229-250
This article presents an overview of evolving diagnostic criteria of pediatric multiple sclerosis and related disorders, emphasizing distinguishing clinical and neuroimaging features that should be considered for differential diagnosis in childhood a
Autor:
Silvia N, Tenembaum
Publikováno v:
Neuroimaging clinics of North America. 27(2)
This article presents an overview of evolving diagnostic criteria of pediatric multiple sclerosis and related disorders, emphasizing distinguishing clinical and neuroimaging features that should be considered for differential diagnosis in childhood a
Autor:
Silvia N. Tenembaum
Publikováno v:
Clinical Neurology and Neurosurgery. 115:S21-S29
Paediatric multiple sclerosis (MS) accounts for up to 5% of all MS cases. No therapies have been formally approved for paediatric patients with MS. However, there is published experience on the use of disease modifying therapies in children and adole
Autor:
Silvia N. Tenembaum
Publikováno v:
Clinical Neurology and Neurosurgery
The advent of MRI has contributed to increase the interest and awareness in childhood white matter disorders. A major priority is to distinguish transient and self-limited demyelinating syndromes like disseminated encephalomyelitis (DEM), from life-l
Autor:
Silvia N, Tenembaum, Brenda, Banwell, Daniela, Pohl, Lauren B, Krupp, Alexey, Boyko, Michael, Meinel, Lorenz, Lehr, Sanda, Rocak, Elisabetta Verdun di, Cantogno, Margaretha Stam, Moraga, Angelo, Ghezzi, Damiano, Baroncini
Publikováno v:
Journal of child neurology. 28(7)
To expand current knowledge, we examined the safety and tolerability of subcutaneous interferon β-1a in patients with pediatric-onset multiple sclerosis. Records from 307 patients who had received at least 1 injection of subcutaneous interferon β-1
Publikováno v:
Journal of Neurology & Neurophysiology.
The scientific world of central nervous system (CNS) neuroinflammatory disorders in general and multiple sclerosis (MS) in particular continues to expand, and 2013 has witnessed interesting advances in many aspects of research. In this review we will
Autor:
Silvia N. Tenembaum
The advent of magnetic resonance imaging (MRI) has contributed to increase the interest and awareness in childhood white matter disorders. Pediatric inflammatory demyelinating diseases of the central nervous system (CNS) are clinically heterogeneous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f8b0283c191d32e8e0ba219e1be20de
https://doi.org/10.1016/b978-0-444-52910-7.00048-9
https://doi.org/10.1016/b978-0-444-52910-7.00048-9